Primary Site >> Pancreatic Cancer
Gene >> USP9X
|
|
|
|---|---|---|
|
Ref: Pancreatic cancer: USP9X can be used to predict pancreatic cancer outcomes. PMID: 22585132 Ref: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. PMID: 22699621 Ref: Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu. PMID: 22759592 |
Ref: Somatic Genetic Variation in Solid Pseudopapillary Tumor of the Pancreas by Whole Exome Sequencing. PMID: 28054945 Ref: Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway. PMID: 28720576 Ref: Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer. PMID: 29130109 |
Ref: Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway. PMID: 29183995 Ref: Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth. PMID: 29248719 Ref: USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy. PMID: 30118840 |